Altered Expression of β-galactosidase-1-like Protein 3 (Glb1l3) in the Retinal Pigment Epithelium (RPE)-specific 65-kDa Protein Knock-out Mouse Model of Leber's Congenital Amaurosis
Overview
Molecular Biology
Ophthalmology
Affiliations
Purpose: In this study, we investigated the expression of the gene encoding β-galactosidase (Glb)-1-like protein 3 (Glb1l3), a member of the glycosyl hydrolase 35 family, during retinal degeneration in the retinal pigment epithelium (RPE)-specific 65-kDa protein knockout (Rpe65(-/-)) mouse model of Leber congenital amaurosis (LCA). Additionally, we assessed the expression of the other members of this protein family, including β-galactosidase-1 (Glb1), β-galactosidase-1-like (Glb1l), and β-galactosidase-1-like protein 2 (Glb1l2).
Methods: The structural features of Glb1l3 were assessed using bioinformatic tools. mRNA expression of Glb-related genes was investigated by oligonucleotide microarray, real-time PCR, and reverse transcription (RT) -PCR. The localized expression of Glb1l3 was assessed by combined in situ hybridization and immunohistochemistry.
Results: Glb1l3 was the only Glb-related member strongly downregulated in Rpe65(-/-) retinas before the onset and during progression of the disease. Glb1l3 mRNA was only expressed in the retinal layers and the RPE/choroid. The other Glb-related genes were ubiquitously expressed in different ocular tissues, including the cornea and lens. In the healthy retina, expression of Glb1l3 was strongly induced during postnatal retinal development; age-related increased expression persisted during adulthood and aging.
Conclusions: These data highlight early-onset downregulation of Glb1l3 in Rpe65-related disease. They further indicate that impaired expression of Glb1l3 is mostly due to the absence of the chromophore 11-cis retinal, suggesting that Rpe65 deficiency may have many metabolic consequences in the underlying neuroretina.
A Genome-Wide Association Study of Prediabetes Status Change.
Liu T, Li H, Conley Y, Primack B, Wang J, Lo W Front Endocrinol (Lausanne). 2022; 13:881633.
PMID: 35769078 PMC: 9234217. DOI: 10.3389/fendo.2022.881633.
Reduced nuclear NAD+ drives DNA damage and subsequent immune activation in the retina.
Brown E, Scandura M, Mehrotra S, Wang Y, Du J, Pierce E Hum Mol Genet. 2021; 31(9):1370-1388.
PMID: 34750622 PMC: 9071398. DOI: 10.1093/hmg/ddab324.
Ebner L, Samardzija M, Storti F, Todorova V, Karademir D, Behr J Sci Rep. 2021; 11(1):16666.
PMID: 34404875 PMC: 8371159. DOI: 10.1038/s41598-021-96150-9.
Jones M, Lu B, Saghizadeh M, Wang S Mol Vis. 2016; 22:472-90.
PMID: 27217715 PMC: 4872275.
Stankowska D, Minton A, Rutledge M, Mueller 2nd B, Phatak N, He S Invest Ophthalmol Vis Sci. 2015; 56(2):893-907.
PMID: 25587060 PMC: 4321399. DOI: 10.1167/iovs.14-15008.